Trademarks Filed by DNEIPER PHARMACEUTICALS

7 trademark applications recorded in the national registry under this applicant name.

The IP India register records 7 trademark applications filed by DNEIPER PHARMACEUTICALS. Filings run from 3 November 2023 to 1 August 2024. The portfolio is concentrated in Class 5 — Pharmaceuticals, which accounts for 100.0% of the filings. The most common registry status across the portfolio is DRAFT (1 mark).

7Applications
1Classes covered
Nov 2023First filing
Aug 2024Latest filing

Classes DNEIPER PHARMACEUTICALS Has Filed In

NICE classes ranked by applications filed under this name. Indian trademark protection extends only to the classes actually filed in — a class absent from this table is not covered by these registrations.
NICE classShare of portfolioApplications
Class 5 — Pharmaceuticals7 (100%)

Registry Status of These Filings

Status is the free-text value the registry records against each application. "Unknown" means no status had been published for that record at the last refresh.
StatusShare of portfolioApplications
Unknown6 (85.7%)
DRAFT1 (14.3%)

All Trademarks Filed by DNEIPER PHARMACEUTICALS

Every trademark application the register attributes to DNEIPER PHARMACEUTICALS, newest filing first. Each row links to that mark's full registry record.

  1. Rosuneip
    App. No. 6555326Class 5Filed 01 Aug 2024
  2. CALNEIPER
    App. No. 6257380Class 5Filed 12 Jan 2024
  3. DPPCure
    App. No. 6257379Class 5Filed 12 Jan 2024
  4. MONPRIME
    App. No. 6257378Class 5Filed 12 Jan 2024
    DRAFT
  5. GMETMG
    App. No. 6243972Class 5Filed 03 Jan 2024
  6. Application No. 6174862
    App. No. 6174862Class 5Filed 03 Nov 2023
  7. Application No. 6174861
    App. No. 6174861Class 5Filed 03 Nov 2023

About this data

Source
Sourced from the official IP India trademark register and the Trade Marks Journal. Only records published by the registry are counted — never applications filed through Trademarx.
Grouped by
The applicant name recorded on each application, normalised for case, spacing and punctuation — so "DNEIPER PHARMACEUTICALS" and its other recorded spellings appear together on this page.
Refreshed
Hourly.
Known limitation
Marks a business holds under a group company, a subsidiary, or a founder's personal name are recorded against those names and appear on their own pages, not here.

Frequently asked questions

How many trademarks does DNEIPER PHARMACEUTICALS have?

7 trademark applications in the IP India register are filed under the name DNEIPER PHARMACEUTICALS, spanning 3 November 2023 to 1 August 2024. This counts filings recorded against that applicant name; marks held under a group company, a subsidiary, or a founder's personal name are recorded separately.

Which trademark classes does DNEIPER PHARMACEUTICALS file in?

Class 5 — Pharmaceuticals is the most-used class, with 7 filings — 100.0% of the portfolio. In total the portfolio covers 1 NICE class. Indian trademark protection only extends to the classes actually filed in, so classes absent from this list are not covered by these registrations.

Can I use a brand name similar to one filed by DNEIPER PHARMACEUTICALS?

Not safely, if it is in a class this applicant already covers. A mark that is identical or deceptively similar to an earlier filing in the same or a related class can be refused by the registry or opposed after publication. Run a clearance search across the relevant classes before adopting a name.

How current is this data?

Sourced from the official IP India trademark register and the Trade Marks Journal. Only records published by the registry are counted — never applications filed through Trademarx. Status and class shown reflect what the Registry has on file at the time of the most recent refresh.

Checking a competitor, a partner, or your own portfolio?

Free clearance search, IP India authorised agents, filing from ₹1,499 + govt. fees.

Free Trademark SearchRegister a Trademark

Data sourced from the official IP India trademark registry and Trade Marks Journal, refreshed continuously. Search another company →